Commentary

Article

State of the Science Summit - Women's Health: Chaired by Britt Erickson, MD

Author(s):

Mayo Clinic

In Partnership With:

State of the Science Summit - Women's Health: Chaired by Britt Erickson, MD

State of the Science Summit - Women's Health: Chaired by Britt Erickson, MD

State of the Science Summit - Women's Health: Chaired by Britt Erickson, MD

State of the Science Summit - Women's Health: Chaired by Britt Erickson, MD

Speakers

  • Andrea Wahner Hendrickson, MD | Mayo Clinic Comprehensive Cancer Center
  • Anne Blaes, MD, MS | Masonic Cancer Center, University of Minnesota
  • Andrea O’Shea, MD | Masonic Cancer Center, University of Minnesota

Topics

  • How Have PARP Inhibitors Shaped Ovarian Cancer?
  • Antibody-Drug Conjugates (ADCs) in Ovarian Cancer
  • Immunotherapy in Endometrial Cancer
  • Top Five Abstracts in Breast Cancer 2024
  • Treatment Crossroads Workshop: Application of Data

Interested in virtually attending an IPC event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!

Related Videos
Seth Wander, MD, PhD
Nicholas P. McAndrew, MD, MSCE
Xichun Hu, MD, PhD
Hope Rugo, MD, FASCO, and Aditya Bardia, MD, MPH, FASCO
Cynthia X. Ma, MD, PhD
Domenica Lorusso, MD, PhD
Ann H. Partridge, MD, MPH
Hope Rugo, MD, FASCO, and Aditya Bardia, MD, MPH, FASCO
Virginia Kaklamani, MD
Hope Rugo, MD, FASCO, and Aditya Bardia, MD, MPH, FASCO
Related Content
Yuan Yuan, MD, PhD, a professor of medicine, the director of Breast Oncology, and the medical director of the Breast Oncology Disease Research Group at Cedars-Sinai Medical Center in Los Angeles, California, as well as a health sciences clinical professor at the University of California, Los Angeles
October 8th 2024

ADC and CDK4/6 Inhibitor Decision-Making and Sequencing Questions Abound in Breast Cancer

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

Joseph A. Sparano, MD, of Mount Sinai
October 7th 2024

Next Generation of CDK Inhibitors Are Breaking Ground in HER2– Breast Cancer

MedNews Week
September 4th 2024

Park and Graff Explore the Evolving Role of CDK4/6 Inhibitors in Metastatic Breast Cancer

Perioperative nivolumab receives FDA approval for resectable NSCLC, acalabrutinib sNDA gets priority review for MCL, and more from OncLive this week.
October 5th 2024

The OncFive: Top Oncology Articles for the Week of 9/29

Yuan Yuan, MD, PhD, a professor of medicine, the director of Breast Oncology, and the medical director of the Breast Oncology Disease Research Group at Cedars-Sinai Medical Center in Los Angeles, California. She is also a health sciences clinical professor at the University of California, Los Angeles.
October 5th 2024

Research Seeks to Establish the Efficacy of Minimally Invasive Breast Cancer Procedures and Tests